Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease
Identifieur interne : 008429 ( Main/Merge ); précédent : 008428; suivant : 008430Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease
Auteurs : le Couteur [Australie] ; Peter W. Leighton [Australie] ; Sally J. Mccann [Australie] ; Susan M. Pond [Australie]Source :
- Movement Disorders [ 0885-3185 ] ; 1997-09.
English descriptors
- KwdEn :
- Age of Onset, Aged, Alleles, Carrier Proteins (genetics), Case-Control Studies, Chi-Square Distribution, Confidence Intervals, Disease Susceptibility, Dopamine Plasma Membrane Transport Proteins, Dopamine transporter, Female, Gene Frequency, Genotype, Humans, Male, Membrane Glycoproteins, Membrane Transport Proteins, Nerve Tissue Proteins, Odds Ratio, Parkinson Disease (genetics), Parkinson's disease, Polymorphism, Polymorphism, Genetic (genetics), Repetitive Sequences, Nucleic Acid (genetics), Repetitive Sequences, Nucleic Acid (physiology), Variable‐number tandem repeat.
- MESH :
- chemical , genetics : Carrier Proteins.
- genetics : Parkinson Disease, Polymorphism, Genetic, Repetitive Sequences, Nucleic Acid.
- physiology : Repetitive Sequences, Nucleic Acid.
- Age of Onset, Aged, Alleles, Case-Control Studies, Chi-Square Distribution, Confidence Intervals, Disease Susceptibility, Dopamine Plasma Membrane Transport Proteins, Female, Gene Frequency, Genotype, Humans, Male, Membrane Glycoproteins, Membrane Transport Proteins, Nerve Tissue Proteins, Odds Ratio.
Abstract
The presynaptic dopamine transporter in nigral dopaminergic neurons confers susceptibility to the cytotoxic effects of the neurotoxic metabolite of 1‐methy1‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Polymorphisms in the dopamine transporter might influence the susceptibility to such toxins. Therefore, we investigated whether a polymorphic region in the 3′‐untranslated region of the dopamine‐transporter gene is associated with idiopathic Parkinson's disease (PD). The frequency distribution of the alleles was significantly different between the patients (n = 100) and controls (n = 200, p < 0.05). The rare 11‐copy allele was more common in the patients (odds ratio = 10.2, 95% confidence interval = 1.2‐87.9, p < 0.025). The susceptibility of some people to PD may be conferred by polymorphisms in the dopamine‐transporter gene that could lead to increased cellular accumulation of neurotoxic compounds in dopaminergic neurons.
Url:
DOI: 10.1002/mds.870120523
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003203
- to stream Istex, to step Curation: 003203
- to stream Istex, to step Checkpoint: 003A24
- to stream PubMed, to step Corpus: 004594
- to stream PubMed, to step Curation: 004594
- to stream PubMed, to step Checkpoint: 004713
- to stream Ncbi, to step Merge: 004D89
- to stream Ncbi, to step Curation: 004D89
- to stream Ncbi, to step Checkpoint: 004D89
Links to Exploration step
ISTEX:6F1D130494B9C0301723AFA278CEBA9DC1FE54B9Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease</title>
<author><name sortKey="Le Couteur" sort="Le Couteur" uniqKey="Le Couteur" last="Le Couteur">le Couteur</name>
</author>
<author><name sortKey="Leighton, Peter W" sort="Leighton, Peter W" uniqKey="Leighton P" first="Peter W." last="Leighton">Peter W. Leighton</name>
</author>
<author><name sortKey="Mccann, Sally J" sort="Mccann, Sally J" uniqKey="Mccann S" first="Sally J." last="Mccann">Sally J. Mccann</name>
</author>
<author><name sortKey="Pond, Susan M" sort="Pond, Susan M" uniqKey="Pond S" first="Susan M." last="Pond">Susan M. Pond</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6F1D130494B9C0301723AFA278CEBA9DC1FE54B9</idno>
<date when="1997" year="1997">1997</date>
<idno type="doi">10.1002/mds.870120523</idno>
<idno type="url">https://api.istex.fr/document/6F1D130494B9C0301723AFA278CEBA9DC1FE54B9/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003203</idno>
<idno type="wicri:Area/Istex/Curation">003203</idno>
<idno type="wicri:Area/Istex/Checkpoint">003A24</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Le Couteur:association:of:a</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:9380062</idno>
<idno type="wicri:Area/PubMed/Corpus">004594</idno>
<idno type="wicri:Area/PubMed/Curation">004594</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004713</idno>
<idno type="wicri:Area/Ncbi/Merge">004D89</idno>
<idno type="wicri:Area/Ncbi/Curation">004D89</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004D89</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Le Couteur D:association:of:a</idno>
<idno type="wicri:Area/Main/Merge">008429</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease</title>
<author><name sortKey="Le Couteur" sort="Le Couteur" uniqKey="Le Couteur" last="Le Couteur">le Couteur</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba</wicri:regionArea>
<wicri:noRegion>Woolloongabba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Leighton, Peter W" sort="Leighton, Peter W" uniqKey="Leighton P" first="Peter W." last="Leighton">Peter W. Leighton</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba</wicri:regionArea>
<wicri:noRegion>Woolloongabba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mccann, Sally J" sort="Mccann, Sally J" uniqKey="Mccann S" first="Sally J." last="Mccann">Sally J. Mccann</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba</wicri:regionArea>
<wicri:noRegion>Woolloongabba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pond, Susan M" sort="Pond, Susan M" uniqKey="Pond S" first="Susan M." last="Pond">Susan M. Pond</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba</wicri:regionArea>
<wicri:noRegion>Woolloongabba</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1997-09">1997-09</date>
<biblScope unit="vol">12</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="760">760</biblScope>
<biblScope unit="page" to="763">763</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">6F1D130494B9C0301723AFA278CEBA9DC1FE54B9</idno>
<idno type="DOI">10.1002/mds.870120523</idno>
<idno type="ArticleID">MDS870120523</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Age of Onset</term>
<term>Aged</term>
<term>Alleles</term>
<term>Carrier Proteins (genetics)</term>
<term>Case-Control Studies</term>
<term>Chi-Square Distribution</term>
<term>Confidence Intervals</term>
<term>Disease Susceptibility</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Dopamine transporter</term>
<term>Female</term>
<term>Gene Frequency</term>
<term>Genotype</term>
<term>Humans</term>
<term>Male</term>
<term>Membrane Glycoproteins</term>
<term>Membrane Transport Proteins</term>
<term>Nerve Tissue Proteins</term>
<term>Odds Ratio</term>
<term>Parkinson Disease (genetics)</term>
<term>Parkinson's disease</term>
<term>Polymorphism</term>
<term>Polymorphism, Genetic (genetics)</term>
<term>Repetitive Sequences, Nucleic Acid (genetics)</term>
<term>Repetitive Sequences, Nucleic Acid (physiology)</term>
<term>Variable‐number tandem repeat</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Carrier Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Parkinson Disease</term>
<term>Polymorphism, Genetic</term>
<term>Repetitive Sequences, Nucleic Acid</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Repetitive Sequences, Nucleic Acid</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Age of Onset</term>
<term>Aged</term>
<term>Alleles</term>
<term>Case-Control Studies</term>
<term>Chi-Square Distribution</term>
<term>Confidence Intervals</term>
<term>Disease Susceptibility</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Female</term>
<term>Gene Frequency</term>
<term>Genotype</term>
<term>Humans</term>
<term>Male</term>
<term>Membrane Glycoproteins</term>
<term>Membrane Transport Proteins</term>
<term>Nerve Tissue Proteins</term>
<term>Odds Ratio</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The presynaptic dopamine transporter in nigral dopaminergic neurons confers susceptibility to the cytotoxic effects of the neurotoxic metabolite of 1‐methy1‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Polymorphisms in the dopamine transporter might influence the susceptibility to such toxins. Therefore, we investigated whether a polymorphic region in the 3′‐untranslated region of the dopamine‐transporter gene is associated with idiopathic Parkinson's disease (PD). The frequency distribution of the alleles was significantly different between the patients (n = 100) and controls (n = 200, p < 0.05). The rare 11‐copy allele was more common in the patients (odds ratio = 10.2, 95% confidence interval = 1.2‐87.9, p < 0.025). The susceptibility of some people to PD may be conferred by polymorphisms in the dopamine‐transporter gene that could lead to increased cellular accumulation of neurotoxic compounds in dopaminergic neurons.</div>
</front>
</TEI>
<double doi="10.1002/mds.870120523"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease</title>
<author><name sortKey="Le Couteur" sort="Le Couteur" uniqKey="Le Couteur" last="Le Couteur">le Couteur</name>
</author>
<author><name sortKey="Leighton, Peter W" sort="Leighton, Peter W" uniqKey="Leighton P" first="Peter W." last="Leighton">Peter W. Leighton</name>
</author>
<author><name sortKey="Mccann, Sally J" sort="Mccann, Sally J" uniqKey="Mccann S" first="Sally J." last="Mccann">Sally J. Mccann</name>
</author>
<author><name sortKey="Pond, Susan M" sort="Pond, Susan M" uniqKey="Pond S" first="Susan M." last="Pond">Susan M. Pond</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6F1D130494B9C0301723AFA278CEBA9DC1FE54B9</idno>
<date when="1997" year="1997">1997</date>
<idno type="doi">10.1002/mds.870120523</idno>
<idno type="url">https://api.istex.fr/document/6F1D130494B9C0301723AFA278CEBA9DC1FE54B9/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003203</idno>
<idno type="wicri:Area/Istex/Curation">003203</idno>
<idno type="wicri:Area/Istex/Checkpoint">003A24</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Le Couteur:association:of:a</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease</title>
<author><name sortKey="Le Couteur" sort="Le Couteur" uniqKey="Le Couteur" last="Le Couteur">le Couteur</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba</wicri:regionArea>
<wicri:noRegion>Woolloongabba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Leighton, Peter W" sort="Leighton, Peter W" uniqKey="Leighton P" first="Peter W." last="Leighton">Peter W. Leighton</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba</wicri:regionArea>
<wicri:noRegion>Woolloongabba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mccann, Sally J" sort="Mccann, Sally J" uniqKey="Mccann S" first="Sally J." last="Mccann">Sally J. Mccann</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba</wicri:regionArea>
<wicri:noRegion>Woolloongabba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pond, Susan M" sort="Pond, Susan M" uniqKey="Pond S" first="Susan M." last="Pond">Susan M. Pond</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba</wicri:regionArea>
<wicri:noRegion>Woolloongabba</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1997-09">1997-09</date>
<biblScope unit="vol">12</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="760">760</biblScope>
<biblScope unit="page" to="763">763</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">6F1D130494B9C0301723AFA278CEBA9DC1FE54B9</idno>
<idno type="DOI">10.1002/mds.870120523</idno>
<idno type="ArticleID">MDS870120523</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dopamine transporter</term>
<term>Parkinson's disease</term>
<term>Polymorphism</term>
<term>Variable‐number tandem repeat</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The presynaptic dopamine transporter in nigral dopaminergic neurons confers susceptibility to the cytotoxic effects of the neurotoxic metabolite of 1‐methy1‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Polymorphisms in the dopamine transporter might influence the susceptibility to such toxins. Therefore, we investigated whether a polymorphic region in the 3′‐untranslated region of the dopamine‐transporter gene is associated with idiopathic Parkinson's disease (PD). The frequency distribution of the alleles was significantly different between the patients (n = 100) and controls (n = 200, p < 0.05). The rare 11‐copy allele was more common in the patients (odds ratio = 10.2, 95% confidence interval = 1.2‐87.9, p < 0.025). The susceptibility of some people to PD may be conferred by polymorphisms in the dopamine‐transporter gene that could lead to increased cellular accumulation of neurotoxic compounds in dopaminergic neurons.</div>
</front>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease.</title>
<author><name sortKey="Le Couteur, D G" sort="Le Couteur, D G" uniqKey="Le Couteur D" first="D G" last="Le Couteur">D G Le Couteur</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba</wicri:regionArea>
<wicri:noRegion>Woolloongabba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Leighton, P W" sort="Leighton, P W" uniqKey="Leighton P" first="P W" last="Leighton">P W Leighton</name>
</author>
<author><name sortKey="Mccann, S J" sort="Mccann, S J" uniqKey="Mccann S" first="S J" last="Mccann">S J Mccann</name>
</author>
<author><name sortKey="Pond, S M" sort="Pond, S M" uniqKey="Pond S" first="S M" last="Pond">S M Pond</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1997">1997</date>
<idno type="RBID">pubmed:9380062</idno>
<idno type="pmid">9380062</idno>
<idno type="doi">10.1002/mds.870120523</idno>
<idno type="wicri:Area/PubMed/Corpus">004594</idno>
<idno type="wicri:Area/PubMed/Curation">004594</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004713</idno>
<idno type="wicri:Area/Ncbi/Merge">004D89</idno>
<idno type="wicri:Area/Ncbi/Curation">004D89</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004D89</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Le Couteur D:association:of:a</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease.</title>
<author><name sortKey="Le Couteur, D G" sort="Le Couteur, D G" uniqKey="Le Couteur D" first="D G" last="Le Couteur">D G Le Couteur</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba</wicri:regionArea>
<wicri:noRegion>Woolloongabba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Leighton, P W" sort="Leighton, P W" uniqKey="Leighton P" first="P W" last="Leighton">P W Leighton</name>
</author>
<author><name sortKey="Mccann, S J" sort="Mccann, S J" uniqKey="Mccann S" first="S J" last="Mccann">S J Mccann</name>
</author>
<author><name sortKey="Pond, S M" sort="Pond, S M" uniqKey="Pond S" first="S M" last="Pond">S M Pond</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1997" type="published">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Age of Onset</term>
<term>Aged</term>
<term>Alleles</term>
<term>Carrier Proteins (genetics)</term>
<term>Case-Control Studies</term>
<term>Chi-Square Distribution</term>
<term>Confidence Intervals</term>
<term>Disease Susceptibility</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Female</term>
<term>Gene Frequency</term>
<term>Genotype</term>
<term>Humans</term>
<term>Male</term>
<term>Membrane Glycoproteins</term>
<term>Membrane Transport Proteins</term>
<term>Nerve Tissue Proteins</term>
<term>Odds Ratio</term>
<term>Parkinson Disease (genetics)</term>
<term>Polymorphism, Genetic (genetics)</term>
<term>Repetitive Sequences, Nucleic Acid (genetics)</term>
<term>Repetitive Sequences, Nucleic Acid (physiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Carrier Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Parkinson Disease</term>
<term>Polymorphism, Genetic</term>
<term>Repetitive Sequences, Nucleic Acid</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Repetitive Sequences, Nucleic Acid</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Age of Onset</term>
<term>Aged</term>
<term>Alleles</term>
<term>Case-Control Studies</term>
<term>Chi-Square Distribution</term>
<term>Confidence Intervals</term>
<term>Disease Susceptibility</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Female</term>
<term>Gene Frequency</term>
<term>Genotype</term>
<term>Humans</term>
<term>Male</term>
<term>Membrane Glycoproteins</term>
<term>Membrane Transport Proteins</term>
<term>Nerve Tissue Proteins</term>
<term>Odds Ratio</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The presynaptic dopamine transporter in nigral dopaminergic neurons confers susceptibility to the cytotoxic effects of the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Polymorphisms in the dopamine transporter might influence the susceptibility to such toxins. Therefore, we investigated whether a polymorphic region in the 3'-untranslated region of the dopamine-transporter gene is associated with idiopathic Parkinson's disease (PD). The frequency distribution of the alleles was significantly different between the patients (n = 100) and controls (n = 200, p < 0.05). The rare 11-copy allele was more common in the patients (odds ratio = 10.2, 95% confidence interval - 1.2-87.9, p < 0.025). The susceptibility of some people to PD may be conferred by polymorphisms in the dopamine-transporter gene that could lead to increased cellular accumulation of neurotoxic compounds in dopaminergic neurons.</div>
</front>
</TEI>
</PubMed>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008429 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 008429 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:6F1D130494B9C0301723AFA278CEBA9DC1FE54B9 |texte= Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease }}
This area was generated with Dilib version V0.6.23. |